Nektar Therapeutics

NASDAQ: NKTR · Real-Time Price · USD
8.56
-0.20 (-2.28%)
At close: Jun 13, 2025, 3:59 PM
8.70
1.58%
After-hours: Jun 13, 2025, 07:18 PM EDT

Nektar Therapeutics Revenue

Nektar Therapeutics reported an annual revenue of $98.43M, reflecting a 9.22% growth. For the quarter ending March 31, 2025, Nektar Therapeutics generated $10.46M in revenue.
Revenue (ttm)
$98.43M
Revenue Growth
9.22%
Price / Sales Ratio
1.94
Revenue / Employee
$1.61M
Employees
61
Market Cap
106.27M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.